Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease

Risdon, 1968, Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis, Lancet, 2, 363, 10.1016/S0140-6736(68)90589-8

Eddy, 1991, A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome, Am J Pathol, 138, 1111

Eddy, 1994, Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions, J Am Soc Nephrol, 5, 1273, 10.1681/ASN.V561273

Peterson, 1995, Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study, Ann Intern Med, 123, 754, 10.7326/0003-4819-123-10-199511150-00003

Remuzzi, 1997, Understanding the nature of renal disease progression, Kidney Int, 51, 2, 10.1038/ki.1997.2

Remuzzi, 1998, Pathophysiology of progressive nephropathies, N Engl J Med, 339, 1448, 10.1056/NEJM199811123392007

Spector, 1975, Fatty acid binding to plasma albumin, J Lipid Res, 16, 165, 10.1016/S0022-2275(20)36723-7

Hamilton, 1991, Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin, Proc Natl Acad Sci U S A, 88, 2051, 10.1073/pnas.88.6.2051

Kees-Folts, 1994, Tubular catabolism of albumin is associated with the release of an inflammatory lipid, Kidney Int, 45, 1697, 10.1038/ki.1994.222

Arici, 2003, Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma, J Am Soc Nephrol, 14, 17, 10.1097/01.ASN.0000042167.66685.EA

Thomas, 1993, Contribution of proteinuria to progressive renal injury, Am J Nephrol, 13, 385, 10.1159/000168653

Thomas, 1995, Metabolic effects of fatty acid–bearing albumin on a proximal tubule cell line, Am J Physiol, 268, F1177

Kamijo, 2002, Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage, Kidney Int, 62, 1628, 10.1046/j.1523-1755.2002.00618.x

Saluja, 1997, Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex, Neurosci Lett, 233, 97, 10.1016/S0304-3940(97)00646-0

Walker, 1988, Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats, J Clin Invest, 81, 334, 10.1172/JCI113325

Maatman, 1992, Molecular identification of the liver- and the heart-type fatty acid–binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction, Biochem J, 288, 285, 10.1042/bj2880285

Nagai, 1984, Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli, Nature, 309, 810, 10.1038/309810a0

Kearney, 1979, A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines, J Immunol, 123, 1548, 10.4049/jimmunol.123.4.1548

Muray, 2002, Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis, Am J Kidney Dis, 39, 60, 10.1053/ajkd.2002.29881

Lin, 1999, Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial, Ann Intern Med, 130, 7, 10.7326/0003-4819-130-1-199901050-00003

Harden, 1997, Effect of renal-artery stenting on progression of renovascular renal failure, Lancet, 349, 1133, 10.1016/S0140-6736(96)10093-3

Ballardie, 2002, Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy, J Am Soc Nephrol, 13, 142, 10.1681/ASN.V131142

Ishida, 2001, Factors affecting renal function in 119 985 adults over three years, Q J Med, 94, 541, 10.1093/qjmed/94.10.541

Nakao, 1999, Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy, Kidney Int Suppl, 71, S206, 10.1046/j.1523-1755.1999.07153.x

Kubo, 1999, Effect of hyperinsulinemia on renal function in a general Japanese population, Kidney Int, 55, 2450, 10.1046/j.1523-1755.1999.00458.x

Soma, 2000, High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy, J Am Soc Nephrol, 11, 690, 10.1681/ASN.V114690

Horio, 1997, Formula and nomogram for predicting creatinine clearance from serum creatinine, Clin Exp Nephrol, 1, 110, 10.1007/BF02479909

Meunier-Durmort, 1996, Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids, Biochem J, 319, 483, 10.1042/bj3190483

Lawrence, 2000, Ligand-dependent interaction of hepatic fatty acid–binding protein with the nucleus, J Lipid Res, 41, 1390, 10.1016/S0022-2275(20)33451-9

Huang, 2002, Liver fatty acid–binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells, J Biol Chem, 277, 29139, 10.1074/jbc.M202923200

Wolfrum, 2001, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator–activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein, Proc Natl Acad Sci U S A, 98, 2323, 10.1073/pnas.051619898

Issemann, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0

Wolfrum, 1999, Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein, J Lipid Res, 40, 708, 10.1016/S0022-2275(20)32150-7

Sheridan, 1993, Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia, Am J Physiol, 265, F342

Humes, 1989, The role of free fatty acids in hypoxia-induced injury to renal proximal tubule cells, Am J Physiol, 256, F688

Matthys, 1984, Lipid alterations induced by renal ischemia, Kidney Int, 26, 153, 10.1038/ki.1984.149

Ramsammy, 1989, Polyaspartic acid protects against gentamicin nephrotoxicity in the rat, J Pharmacol Exp Ther, 250, 149